Odyssey Math Tuition launches a Secondary 2 online math tuition elearning course in Singapore, featuring a proprietary ...

One key figure, however, indicates otherwise as sales for Journavx were at $20 million for the period, coming up $3 million ...

The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...

Pre-earnings options volume in Vertex is 2.7x normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move ...

Return on Assets (ROA): Vertex's financial strength is reflected in its exceptional ROA, which exceeds industry averages.

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

Tylah Tully looks at Vertex Minerals and its growing high-grade gold production in the latest episode of Stockhead's Who’s ...

The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...